LINAPURE-2.5/5 Linagliptin 2.5 mg / 5 mg

In the management of 

Type-2 diabetes mellitu

                       LINAGLIPTIN 

•     Linagliptin is a dipeptidyl peptidase- 4 (DPP-4) inhibitor.
•     Linagliptin differs from other DPP-4 inhibitors in that it has a non linear pharmacokinetic profile, is not primarily                eliminated by the renal system, and obeys concentration dependent protein binding.